Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Situated in Fitchburg, MA, Community Health Connections Inc delivers extensive outpatient services for individuals facing substance use challenges, including adults and children grappling with significant mental health conditions. The center features tailored programs aimed at individuals dealing with HIV/AIDS, as well as those with dual diagnoses involving mental and substance use disorders, along with pain management issues related to substance use. Emphasizing cognitive behavioral therapy and community reinforcement techniques, this facility also provides outpatient options for methadone, buprenorphine, or naltrexone treatments. Catering to adults and seniors of all genders, it prioritizes personalized care and support for those pursuing recovery from addiction and mental health difficulties.
Community Health Connections Inc, located in Fitchburg, MA, provides extensive outpatient treatment for substance use issues in adults and children grappling with concurrent mental health disorders. Their specialized services are designed for those facing both addiction and significant emotional challenges. Offerings include outpatient treatment with methadone/buprenorphine as well as cognitive behavioral therapy. The center employs evidence-based strategies like brief interventions and community reinforcement with vouchers. They focus on customized care for individuals dealing with both chronic pain and substance use issues, accommodating adults and seniors of all genders. Community Health Connections Inc is committed to offering exceptional, personalized rehabilitation services aimed at fostering recovery and overall wellness.
Community Health Connections Inc in Leominster, MA, provides expert outpatient services for individuals of all ages struggling with substance use and related mental health challenges. Their personalized treatment plans incorporate proven methods like cognitive behavioral therapy and community reinforcement. They also offer distinct programs designed for those managing co-occurring mental health and addiction issues, as well as individuals facing the complexities of pain and substance dependence. Welcoming adults and seniors without regard to gender, this center distinguishes itself with a broad spectrum of recovery options, including outpatient medication-assisted treatment with methadone, buprenorphine, or naltrexone. Community Health Connections Inc is dedicated to delivering high-quality, personalized support, making it a reliable choice for anyone on their journey to recovery.
Community Health Resources, situated in Manchester, CT, delivers extensive treatment options for substance use issues alongside targeted support for those experiencing both substance use disorders and significant mental health challenges. It features intensive outpatient and outpatient services, offering treatments such as methadone/buprenorphine and naltrexone. The center emphasizes therapies like anger management, brief intervention, and cognitive behavioral therapy, serving adults, seniors, and providing specific programs for adolescents, men, and women. By implementing a personalized and gender-sensitive approach, this facility guarantees exceptional care for anyone on their journey to recovery and improved mental health.
Community Healthcare Inc, situated in Attleboro, MA, provides targeted substance abuse care via its outpatient services, which encompass methadone, buprenorphine, or naltrexone therapy. The facility delivers personalized support through methodologies such as 12-step program integration, anger resolution, and concise intervention strategies. Distinctive treatment options are available for adult males and females, as well as individuals affected by domestic abuse or violence. Catering to adults and young adults of all genders, this establishment offers thorough assistance for those pursuing sobriety. Emphasizing high-quality treatment and varied program options, Community Healthcare Inc distinguishes itself as a supportive provider for individuals requiring addiction recovery services.
Community Health Connections Inc. in Gardner, MA, delivers outpatient services for adults and children grappling with substance use and co-occurring mental health challenges. Their tailored programs address individuals experiencing mental illness, emotional difficulties, pain, and addiction. Employing proven methods such as cognitive behavioral therapy and community reinforcement, they offer comprehensive care to men and women of all ages, including seniors. This center prioritizes brief interventions and individualized recovery strategies to guide patients toward lasting wellness.
Situated in West Burlington, IA, Community Health Centers of SE IA delivers an extensive array of substance abuse treatment options for both adults and children facing concurrent mental health challenges. The facility offers a variety of treatment modalities, including intensive outpatient services, outpatient care, and medications such as methadone, buprenorphine, and naltrexone. Emphasizing 12-step support, anger management strategies, and brief therapeutic interventions, the center customizes its programs for each individual, promoting a tailored recovery experience. Dedicated to serving all genders among adults and seniors, this center is noted for its pledge to providing exceptional care and personalized treatment strategies.
Community Health Centers of SE IA, situated in West Burlington, IA, specializes in outpatient substance use disorder services for adults grappling with co-occurring severe mental health conditions. They also provide support for children experiencing emotional disturbances. The facility offers medication-assisted treatment options including methadone, buprenorphine, and naltrexone, alongside general outpatient rehabilitation. Their therapeutic interventions emphasize 12-step program integration, brief counseling techniques, and cognitive behavioral therapy, all customized to meet the unique needs of each client. This center is dedicated to delivering effective addiction treatment to both men and women.
Situated in Indianapolis, IN, Community Health Network specializes in outpatient care for adults grappling with substance abuse and concurrent severe mental health conditions, along with emotional issues in children. The center employs a variety of treatment strategies such as 12-step programs, anger management, and brief therapy sessions. It offers customized programs for adolescents, as well as adult men and women, addressing a wide spectrum of needs. Catering to individuals of all ages and genders, Community Health Network provides effective care through outpatient services including methadone/buprenorphine or naltrexone treatment. For those in search of thorough and personalized addiction rehabilitation, this facility stands out as a leading option in the Indianapolis area.
Outpatient substance use treatment with naltrexone is available at this Bangor, Maine, agency serving adults and seniors. A sliding fee scale based on income, SAMHSA block grant funding, Medicaid, Medicare, and most insurance types make it an option for clients with limited resources.
Community Health and Outreach Center in Auburn, Indiana provides outpatient substance use treatment with buprenorphine and naltrexone for children and adolescents, young adults, and seniors. Programs address co-occurring disorders, criminal justice clients, and trauma survivors. Medicare, Medicaid, TRICARE, and a sliding fee scale are accepted, and sign language services are available.
Community Health of South Florida's West Kendall Health Center in Miami provides outpatient substance use treatment with buprenorphine and naltrexone. Children, adolescents, and adults with co-occurring disorders are served. Medicaid, Medicare, TRICARE, SAMHSA block grants, and a sliding fee scale are accepted, with Spanish and sign language services available.
Outpatient detoxification and buprenorphine and naltrexone treatment are available at Community Health of South Florida's Doris Ison Health Center in Miami. Children, adolescents, and adults with co-occurring disorders are served. Medicaid, Medicare, TRICARE, SAMHSA block grants, and a sliding fee scale are accepted, with services in Spanish, Creole, and French.
Situated in Danielson, CT, Community Health Resources delivers extensive treatment solutions for individuals facing substance use challenges, including both adults and young adults. The center specializes in addressing co-occurring substance use disorders and serious mental health conditions in adults, along with emotional issues in children. It offers both intensive outpatient and outpatient programs. Treatment methodologies include anger management, brief intervention, and cognitive behavioral therapy, accommodating both male and female clients, including survivors of sexual abuse. With an emphasis on personalized care and high-quality support, Community Health Resources stands out as a reliable option for effective rehabilitation services.
This Kokomo, Indiana hospital unit delivers inpatient detoxification and inpatient treatment for substance use and co-occurring serious mental illness, using buprenorphine and naltrexone. Programs cover young adults, pregnant and postpartum women, seniors, veterans, military families, and clients with HIV or AIDS or trauma histories. Medicare, Medicaid, and TRICARE are accepted, with sign language services.
Situated in Monterey, CA, the Community Hospital of the Monterey delivers all-encompassing treatment for substance abuse aimed at adults and adolescents. This center offers a range of options including intensive outpatient programs, general outpatient services, and medication-assisted treatments like methadone/buprenorphine and naltrexone. Employing scientifically-backed methods such as 12-step support, brief interventions, and motivational techniques, the facility customizes its treatment plans to meet individual requirements. Prioritizing personalized attention, the center serves both men and women who are on the path to overcoming addiction. For those seeking effective rehabilitation services infused with compassion, the Community Hospital of the Monterey is dedicated to aiding you in your recovery journey.
Community Health Centers of SE IA, situated in Keokuk, IA, delivers a variety of expert rehabilitation programs. This facility offers robust intensive outpatient options, general outpatient services, and specialized medication-assisted treatment (methadone/buprenorphine or naltrexone) for individuals battling substance use disorders and related mental health challenges. Designed for adults and seniors across all demographics, the center emphasizes personalized treatment plans. Employing methods like 12-step facilitation, anger management techniques, and brief intervention strategies, they ensure a thorough rehabilitation process. For those looking for customized recovery paths within a nurturing setting, this establishment is committed to offering excellent support throughout your healing process.
Situated in Putnam, CT, Community Health Resources delivers thorough treatment for substance use issues along with dedicated support for those facing severe mental health challenges concurrently. The center features various programs, including long-term residential care, outpatient services, and medication-assisted treatments. Employing methodologies such as 12-step guidance, anger management sessions, and cognitive behavioral therapy, the facility serves adult women and individuals who have endured trauma or sexual abuse. With an emphasis on tailored care for both adult and young adult populations, Community Health Resources is committed to promoting recovery and enhancing overall wellness.
At Community Hospitals of Indiana Inc in Indianapolis, IN, we offer extensive recovery support for both younger and older individuals facing addiction and accompanying mental health challenges. Our hospital-based services include inpatient detoxification and comprehensive treatment programs, with distinct tracks designed for teens, adult men, and adult women. We employ proven therapeutic methods like 12-step encouragement, emotional regulation training, and short-term counseling to foster lasting sobriety and mental wellness. Our commitment is to provide personalized, high-quality care aimed at improving each person's overall health.
Situated in Salinas, CA, Community Human Services offers outpatient treatment for substance use aimed at both adults and young adults. The center provides a range of options including outpatient methadone/buprenorphine or naltrexone therapies, standard outpatient services, and tailored programs for adult men, women, and individuals who have faced intimate partner or domestic violence. Utilizing proven methods such as brief interventions, cognitive behavioral therapy, and motivational interviewing, the center is dedicated to delivering thorough care. Emphasizing personalized treatment plans, this facility serves both genders, ensuring effective rehabilitation services to promote healing and well-being.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.